Bromantane
Enhance dopamine production
Key takeaways
- Improve focus
- Enhance cognitive function
- Reduce fatigue
- Increase creativity
From food to dopamine, atom by atom
4 molecules3 enzymes2 that bromantane turns up
Molecule 1 of 4 · from food
Phenylalanine C₉H₁₁NO₂
An essential amino acid: the body cannot make it, so it comes from protein in food. This is where dopamine starts. Its six-carbon ring has no OH groups yet. The dashed ring marks the hydrogen that the next enzyme, PAH, swaps for an OH.
- Formula
- C₉H₁₁NO₂
- Mass
- 165.19 g/mol
- Comes from
- Protein in food
- Next step
- PAH, mostly in the liver
Molecule 2 of 4 · step 1, PAH
Tyrosine C₉H₁₁NO₃
Phenylalanine hydroxylase (PAH), mostly in the liver, adds one OH group at the far end of the ring (position 4). One oxygen atom more, everything else unchanged. Tyrosine also comes straight from food, and the LAT1 transporter carries it across the blood-brain barrier into the brain.
- Formula
- C₉H₁₁NO₃
- Mass
- 181.19 g/mol
- Made by
- PAH, needs BH4 and iron
- Into the brain
- LAT1 transporter
- Bromantane
- Not studied at this step
Molecule 3 of 4 · step 2, TH · the bottleneck
L-DOPA C₉H₁₁NO₄
Tyrosine hydroxylase (TH) adds a second OH, right next to the first (position 3). Two OH groups side by side on a ring are called a catechol, which is why dopamine is a catecholamine. This is the slowest step, so how much TH a neuron has sets how much dopamine it can make.
- Formula
- C₉H₁₁NO₄
- Mass
- 197.19 g/mol
- Made by
- TH, needs BH4, iron and oxygen
- Speed
- Slow, the rate-limiting step
- Bromantane
- More TH gene expression (rats)
Bromantane acts here. In rats, one dose of bromantane (Ladasten, 50 mg/kg) increased expression of the TH gene in the striatum and hypothalamus. L-DOPA and dopamine built up in step with that gene activity, and the authors concluded it works through new synthesis of TH and DDC [1].
Molecule 4 of 4 · step 3, AADC
Dopamine C₈H₁₁NO₂
Aromatic L-amino acid decarboxylase (AADC, also called DOPA decarboxylase or DDC) cuts the COOH group off L-DOPA, and it leaves as CO₂. A hydrogen takes its place. What is left is dopamine: no longer an amino acid, and no longer left- or right-handed. This step is fast, so L-DOPA rarely piles up.
- Formula
- C₈H₁₁NO₂
- Mass
- 153.18 g/mol
- Made by
- AADC (DDC), needs vitamin B6
- Speed
- Fast
- Bromantane
- More DDC gene expression (rats)
Bromantane acts here. The same rat study measured the DDC gene too: it rose along with TH, so bromantane turns up both enzymes on the road from tyrosine to dopamine. In the first hours after the dose, dopamine release also rose; the gene effect came after [1].
What is bromantane?
Bromantane (also spelled bromantan) is a synthetic adamantane derivative developed in the Soviet Union and later registered in Russia under the brand name Ladasten, for asthenia: persistent fatigue, low drive and weakness. Pharmacologists classify it as an actoprotector, a compound that improves the body's stability under physical load without increasing oxygen consumption or heat production [2]. In other words, a "synthetic adaptogen" rather than a classic stimulant.
How does bromantane work?
This is what makes bromantane interesting. Stimulants like amphetamine or methylphenidate push existing dopamine into the synapse or stop it from being cleared. Bromantane appears to raise the capacity to make dopamine:
- Dopamine synthesis genes. In rats, a single dose increased expression of the genes for tyrosine hydroxylase (TH) and DOPA-decarboxylase (DDC), the two enzymes that turn tyrosine into L-DOPA and L-DOPA into dopamine. L-DOPA and dopamine rose in the striatum and hypothalamus in step with that gene activity [1].
- Neurotrophins. It also increased gene expression for BDNF and NGF and activated the ERK1/2 signalling cascade in rat brain [3].
- Serotonin. Rat studies show increased serotonin and its metabolite in the frontal cortex [4].
The practical implication people care about: because it works upstream on synthesis rather than forcing release, it is described as producing less of a crash than classic stimulants. That idea is consistent with the mechanism, but it has not been tested head-to-head in proper trials.
01People · 728 patients
76% to 91% of 728 fatigue patients responded

The largest human study of bromantane. 728 patients with asthenia (lasting fatigue and weakness) and autonomic symptoms took Ladasten at 50 to 100 mg a day for 28 days. By the doctors' global ratings, 76.0% responded on the severity scale (CGI-S) and 90.8% on the improvement scale (CGI-I). The effect on fatigue showed from day 3 and still held one month after the last dose, with better anxiety, sleep and quality of life as well. Side effects were recorded in 3% of patients, 0.8% stopped the drug and none were serious. The catch: every patient knew they were on the drug and there was no placebo group, so part of the response may be expectation. [5]
PMID 21322821 on PubMed02Rats + rat brain tissue
It raises dopamine making, not a stimulant-style reuptake block

This study asked how bromantane differs from a classic stimulant. One dose raised the making and release of dopamine in the striatum and left serotonin production alone; the stimulant sydnocarb did the opposite, lowering serotonin synthesis without touching dopamine synthesis. Neither drug acted directly on dopamine or serotonin receptors. Both blocked dopamine reuptake in rat brain tissue, but bromantane needed a concentration of 3.56 µM against 28.66 nM for sydnocarb, about 124 times more. Reuptake blocking is how stimulants work, and bromantane is a weak blocker, which fits with its main effect being more dopamine made. [6]
PMID 20369592 on PubMed03Rats
One dose more than doubled the dopamine-enzyme gene

Tyrosine hydroxylase (TH) is the slowest step on the road from tyrosine to dopamine, so how much of it a neuron makes sets its dopamine output. The group's earlier work found that one dose of bromantane more than doubled TH messenger RNA in the rat hypothalamus 1.5 to 2 hours later. This study looked for the switch: bromantane removed methyl tags, the chemical marks that keep a gene quiet, from control sites in the TH gene promoter. The authors suggest that is how the gene gets read more. Rat brain only; the doubling is quoted from the earlier study, and the chart draws it at 2×, the lowest value "more than twofold" allows. [7]
PMID 16915929 on PubMed04Rats and mice
A stimulant profile with better memory, at very low toxicity

An early profile of what bromantane does in animals. It activated both simple and complex behaviour, produced brain-wave (EEG) changes typical of stimulants, countered drugs that dampen the nervous system, improved memory and helped rats perform complex learned tasks. The lethal dose for half of the mice (LD50, injected into the abdomen) was 8,100 mg/kg, a very high number, which means low acute toxicity. The abstract gives directions but no effect sizes, and acute toxicity in mice says nothing about long-term use in people. [8]
PMID 10340117 on PubMed05Rats
L-DOPA rose across the rat brain: the dopamine enzyme at work

A clean way to see whether TH is working harder: block the enzyme after it (AADC) so L-DOPA cannot turn into dopamine, then measure how much L-DOPA piles up. With bromantane, L-DOPA rose in virtually every brain region tested except the hippocampus, which points to more TH activity. Only dopamine measures moved: turnover sped up in the nucleus accumbens, the reward centre, and in the hippocampus, and the breakdown product HVA rose in the nucleus accumbens but fell in the hypothalamus. Serotonin was left alone. Rats only, and the abstract reports directions without numbers. [9]
PMID 20408420 on PubMed06Rats
Long work done smarter: fewer errors, not just more effort

Rats worked for 5 hours at a task where the right response avoided a mild shock. Both drugs made them more efficient, in different ways. The stimulant sydnocarb made them respond more, drained the reserves of the adrenal stress system and weakened their drive to avoid the shock. Bromantane made them respond less but with fewer errors, and their drive to avoid the shock got stronger. Neither drug changed how hard the heart and vessels were working. Rats only, and the abstract reports directions without numbers. [10]
PMID 10934588 on PubMedWhat is bromantane's half-life?
A half-life of about 11 hours in humans is widely quoted online. I could not find a PubMed abstract with human pharmacokinetic data to confirm it, so treat that number as unverified. The one pharmacokinetic paper indexed in PubMed is a 1995 Russian animal study with no English abstract.
Frequently asked questions
Is bromantane safe?
In a Russian multicenter study of 728 patients taking 50 to 100 mg a day, side effects were recorded in 3% and none were serious. There are no long-term studies and no large trials outside Russia, and it is not an approved drug in the US or EU.
How does bromantane work?
In rat studies it increases the expression of the genes for tyrosine hydroxylase and DOPA-decarboxylase, the two enzymes that make dopamine. It raises the capacity to produce dopamine instead of blocking its reuptake.
What is the half-life of bromantane?
About 11 hours is widely quoted, but there is no English-language PubMed abstract with human pharmacokinetic data to confirm it.
Is bromantane addictive?
In a placebo-controlled study in neurasthenia, patients showed no withdrawal syndrome after stopping it, which the authors took as a lack of addictive potential. Long-term data is missing.
What does bromantane do?
It is an actoprotector used in Russia (as Ladasten) for fatigue and low drive. In animal studies it increases the expression of the enzymes that make dopamine, rather than forcing dopamine release like classic stimulants.
Is bromantane a stimulant?
Not in the classic sense. In rat brain tissue it blocks dopamine reuptake only weakly, about 124 times more weakly than the stimulant sydnocarb, and it raises dopamine production instead. It is classified as an actoprotector, with mild stimulating effects reported alongside anti-fatigue effects.
Is bromantane legal in the US?
It is not FDA-approved. It is sold by some suppliers for research use only, and it is prohibited in sport by WADA.
What is the difference between bromantane and Ladasten?
Ladasten is the Russian pharmaceutical brand name for bromantane.
How long does bromantane take to work?
In rat studies dopamine effects began within hours, with gene-expression changes following. Human onset data in English is limited.
Keep reading
- Reset Your Brain's Reward System and Raise Your Dopamine Baseline.
- The Downfall of SSRI Drugs
- Fix your Gut to improve Mood and Cognitive Function.
- Study: Russian smart drugs are kinda crazy.
- Study: Neurons don't touch. Between every single one of them is a tiny gap, they communicate with electrical signals…
More guides:
Sources
- Vakhitova IuV, Iamidanov RS, Seredinin SB Ladasten induces the expression of genes regulating dopamine biosynthesis in various structures of rat brain. Eksp Klin Farmakol 2004. PMID 15500036
- Oliynyk S, Oh S The pharmacology of actoprotectors: practical application for improvement of mental and physical performance. Biomol Ther (Seoul) 2012. PMID 24009833
- Salimgareeva MKh, Yamidanov RS, Vakhitova YV et al. Mechanisms of action of ladasten: activation of gene expression for neurotrophins and mitogen-activated kinases. Bull Exp Biol Med 2012. PMID 22803074
- Kudrin VS, Sergeeva SA, Krasnykh LM et al. [The effect of bromantane on the dopamin- and serotoninergic systems of the rat brain]. Eksp Klin Farmakol 1995. PMID 7580761
- Voznesenskaia TG, Fokina NM, Iakhno NN Treatment of asthenic disorders in patients with psychoautonomic syndrome: results of a multicenter study on efficacy and safety of ladasten. Zh Nevrol Psikhiatr Im S S Korsakova 2010. PMID 21322821
- Zimin IA, Abaimov DA, Budygin EA et al. Role of the brain dopaminergic and serotoninergic systems in psychopharmacological effects of ladasten and sydnocarb. Eksp Klin Farmakol 2010. PMID 20369592
- Vakhitova IuV, Sadovnikov SV, Iamidanov RS et al. Cytosine demethylation in the tyrosine hydroxylase gene promoter in the hypothalamus cells of the rat brain under the action of an aminoadamantane derivative Ladasten. Genetika 2006. PMID 16915929
- Morozov IS, Klimova NV, Karpova TD et al. The characteristics of the neuropsychotropic activity of bromantane in laboratory animals. Eksp Klin Farmakol 1999. PMID 10340117
- Davydova AI, Klodt PM, Kudrin VS et al. Neurochemical study of effects of the new anxiolytic drugs afobazol and ladasten on the synthesis and metabolism of monoamines and their metabolites in the brain structures of Wistar rat on the model of monoamine synthesis blockade induced by aromatic amino acid decarboxylase inhibitor NSD-1015. Eksp Klin Farmakol 2010. PMID 20408420
- Morozov IS, Efimova LP, Salenko IuA [Effects of bromantane and sidnocarb on long-term operant conditioning and its vegetative correlates in rats]. Eksp Klin Farmakol 2000. PMID 10934588
This guide is educational and is not medical advice. Talk to a qualified clinician before starting any compound, especially if you take medication, are pregnant, or compete in tested sport.